Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John Wort

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Scientific Reports|August 30, 2018
The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cellsLatha Ramakrishnan, Sofia L Pedersen, Quezia K Toe, et al.
Thorax|September 17, 2014
Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure modelsJohn E S Park, Alexander R Lyon, Dongmin Shao, et al.
Pulmonary Circulation|August 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary DiseaseSteven D Nathan, Lucilla Piccari, Steven H Abman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 1, 2014
Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapiesGregory John Keir, Simon L F Walsh, Michael A Gatzoulis, et al.
Pulmonary Circulation|December 19, 2024
The hepcidin-ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cellsTheo Issitt, Quezia K Toe, Sofia L Pedersen, et al.
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Chest|July 28, 2019
Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung DiseaseSimon Bax, Joseph Jacob, Riaz Ahmed, et al.
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
European Heart Journal Open|January 15, 2026
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profilingChinthaka B Samaranayake, Yen-Cheng Chen, Min Fang, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Scientific Reports|August 30, 2018
The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cellsLatha Ramakrishnan, Sofia L Pedersen, Quezia K Toe, et al.
Thorax|September 17, 2014
Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure modelsJohn E S Park, Alexander R Lyon, Dongmin Shao, et al.
Pulmonary Circulation|August 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary DiseaseSteven D Nathan, Lucilla Piccari, Steven H Abman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 1, 2014
Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapiesGregory John Keir, Simon L F Walsh, Michael A Gatzoulis, et al.
Pulmonary Circulation|December 19, 2024
The hepcidin-ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cellsTheo Issitt, Quezia K Toe, Sofia L Pedersen, et al.
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Chest|July 28, 2019
Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung DiseaseSimon Bax, Joseph Jacob, Riaz Ahmed, et al.
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
European Heart Journal Open|January 15, 2026
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profilingChinthaka B Samaranayake, Yen-Cheng Chen, Min Fang, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
Pageof 4